PRISM HTLV-I/HTLV-II 6E50-68

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2009-12-28 for PRISM HTLV-I/HTLV-II 6E50-68 manufactured by Abbott Laboratories.

Event Text Entries

[1428460] Reporter alleged the customer obtained the results of 210 mg/dl and 98 mg/dl back to back within 10 minutes on the aviva system. No actions were reported taken or treatment received. No adverse event reported. A request was made for the return of the affected product.
Patient Sequence No: 1, Text Type: D, B5


[1450568] The customer stated that increased initial and repeat reactive prism htlv i/ii have been observed on a prism analyzer for the months of (b)(6) and (b)(6) of 2009. Patient specific data was not provided. There was no adverse impact to patient management reported.
Patient Sequence No: 1, Text Type: D, B5


[8300490] (b)(4) this is an initial report. An investigation is in process. A final report will be submitted when the investigation is complete.
Patient Sequence No: 1, Text Type: N, H10


[8788789] (b)(4) - evaluation - reactivity originating from the htlv-i viral lysate. An investigation was initiated to determine if there were actions that could be taken to improve reactive rates with the prism htlv-i/htlv-ii assay. 30 of 79 prism htlv-i / htlv-ii reagent lots, list number 06e50-68, have exhibited initial reactive rates (irr) and/or repeat reactive rates (rrr) that exceed the package insert 95% confidence interval upper limit. Multiple customer complaints related to reactive rates from several sites representing various geographic areas for these lots have been received since 7/30/08. There was no impact to product functionality or product performance. The probable cause of some reagent lots exhibiting irr and/or rrr that exceed the package insert 95% confidence interval upper limit is that these clinical results were obtained from the 3 clinical lots combined and does not accurately represent the individual clinical lot irr and rrr performance. A contributing factor for the higher than expected repeat reactive rates observed at multiple customer sites for the prism htlv-i/htlv-ii assay is a sample-specific antibody interaction with the microparticle and probe components of the assay reagents. The target of this reactivity originates from the htlv-i viral lysate.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1415939-2009-01207
MDR Report Key1565233
Report Source05
Date Received2009-12-28
Date of Report2009-12-17
Date of Event2009-12-17
Date Mfgr Received2010-08-17
Device Manufacturer Date2009-09-24
Date Added to Maude2010-09-15
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactNOEMI KONDOS RN, BSN
Manufacturer Street200 ABBOTT PARK ROAD DEPT. 09B9, AP50
Manufacturer CityABBOTT PARK IL 600643537
Manufacturer CountryUS
Manufacturer Postal600643537
Manufacturer Phone8479375120
Manufacturer G1ABBOTT LABORATORIES
Manufacturer Street100 ABBOTT PARK ROAD
Manufacturer CityABBOTT PARK IL 60064350
Manufacturer CountryUS
Manufacturer Postal Code60064 3500
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NamePRISM HTLV-I/HTLV-II
Generic NameFOR DETECTION OF HTLV-I/ HTLV-II ANTIBODIES IN HUMAN SERUM OR PLASMA
Product CodeMTP
Date Received2009-12-28
Catalog Number6E50-68
Lot Number77622M100
ID Number77620M100, EXP 7/18/10
Device Expiration Date2010-07-04
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerABBOTT LABORATORIES
Manufacturer Address100 ABBOTT PARK ROAD ABBOTT PARK IL 60064350 US 60064 3500


Patients

Patient NumberTreatmentOutcomeDate
10 2009-12-28

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.